SCHEMBL20373741

SCHEMBL20373741

COc1cc2c(cc1I)cc(C)c(=O)n2CCc1ccc(Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.41
▸ ALDH1A1 P00352 6/20 0.40
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ MAPT P10636 3/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ RECQL P46063 1/20 0.39
▸ P2RX7 Q99572 2/20 0.39
▸ BRD4 O60885 2/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ HTT P42858 1/20 0.36
▸ UBE2N P61088 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ DHCR7 Q9UBM7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18326374 0.86 HTR2A (0.41) LMNAALDH1A1SMN1; SMN2MAPTKMT2A
SCHEMBL16905797 0.78 BRD4 (0.42) BRD4CYP3A4CYP2C9
SCHEMBL20373740 0.75 MEN1 (0.41) ALDH1A1SMN1; SMN2MAPTKMT2AMEN1
SCHEMBL16896795 0.74 HTR2A (0.41) LMNAALDH1A1SMN1; SMN2MAPTKMT2A
SCHEMBL18359550 0.70 BRD4 (0.40) BRD4CYP3A4CYP2C9
SCHEMBL22549219 0.70 GABRA5 (0.45) ALDH1A1MAPTKMT2AMEN1BRD4
SCHEMBL16896809 0.69 BRD4 (0.41) BRD4CYP3A4CYP2C9
SCHEMBL16896824 0.69 BRD4 (0.39) BRD4RXFP1CYP3A4CYP2C9
SCHEMBL20373363 0.69 MAPT (0.35) LMNAALDH1A1SMN1; SMN2MAPTKMT2A
SCHEMBL20357634 0.68 BRD4 (0.40) ALDH1A1SMN1; SMN2KMT2ARECQLBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3092227-B1 BICYCLIC HETEROCYCLIC DERIVATIVES AS BROMODOMAIN INHIBITORS ORION CORP (FI) 2018-07-11 — — EP disclosed
Send feedback